Glipizide
- Product NDC
- 50090-7755
- 11-digit product format
- 500907755
- Labeler code
- 50090
- Product ID
- 50090-7755_3dd01f27-56bf-4b79-b445-7be43156372b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA214874
- Marketing category
- ANDA
- Marketing start
- 2023-10-03
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310490 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7755-0 | 50090775500 | 30 TABLET in 1 BOTTLE (50090-7755-0) | 30 tablet | 2025-11-05 | No | No | Current |
| 50090-7755-1 | 50090775501 | 60 TABLET in 1 BOTTLE (50090-7755-1) | 60 tablet | 2025-11-05 | No | No | Current |
| 50090-7755-2 | 50090775502 | 100 TABLET in 1 BOTTLE (50090-7755-2) | 100 tablet | 2025-11-05 | No | No | Current |
| 50090-7755-3 | 50090775503 | 90 TABLET in 1 BOTTLE (50090-7755-3) | 90 tablet | 2025-11-05 | No | No | Current |
| 50090-7755-4 | 50090775504 | 180 TABLET in 1 BOTTLE (50090-7755-4) | 180 tablet | 2025-11-05 | No | No | Current |